MGD STRATEGIES LLC for ESOPHAGEAL CANCER ACTION NETWORK (ECAN)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Inclusion of esophageal cancer in the FY 2026 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2026 LHHS Appropriations bill Inclusion of esophageal cancer in the FY 2027 Department of Defense's Peer-Reviewed Cancer Research Program Inclusion of report language in the FY 2027 LHHS Appropriations bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN GORDON DON | — |
Health Issues HCR
Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN GORDON DON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.